user-group INVESTOR ACCESS
Search
Close this search box.
  1. Home
  2. /
  3. Venture Capital
  4. /
  5. Deepull appoints Didier Deltort...

News / Venture Capital

Deepull appoints Didier Deltort to its Board of Directors.

22 May 2024
Deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification for sepsis and other acute infections, today announces the appointment of Didier Deltort to its Board of Directors.

Download

Press Release
Download

Related News

  • Venture Capital
  • Other news

Private Corner lance un feeder sur le thème de la santé avec Mérieux Equity Partners, pour son fonds Mérieux Innovation 2

arrow-up-right
  • Venture Capital
  • Other news

The Mérieux Innovation 2 fund is awarded the Tibi label, in recognition of its support to healthcare innovation in France and Europe, for the benefit of patients.

arrow-up-right
  • Buyout
  • Other news

Integrating Nature: at the heart of our “One Health” approach.

arrow-up-right
Lyon
Paris
Contact
  • ⓒ MERIEUX EQUITY PARTNERS 2023
  • Mérieux Equity Partners vehicles are only open to Professional Clients - as defined in the French Monetary code (CMF) and AMF regulation (RG).